Abstract
The methods currently used to determine the immunoglobulin avidity index (AI) require the choice of a reference point in the ELISA titration curve. Since both curves, with and without denaturating reagents, seldom run in parallel, the AI value becomes highly dependent on this reference. The new method for AI calculation presented here takes into account the whole data of the ELISA titration curve in which the final numerical AI is the average of each point. J. Clin. Lab. Anal. 21:201–206, 2007. © 2007 Wiley‐Liss, Inc.
Keywords: oil/water emulsion, porcine pulmonary surfactant, outer membrane vesicle, meningococcal vaccine
REFERENCES
- 1. Hedman K, Lappalainen M, Seppaia I, Makela O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 1989;159:736–740. [DOI] [PubMed] [Google Scholar]
- 2. Wilson KM, Di Camili C, Doughty L, Dax EM. Humoral response to primary rubella virus infection. Clin Vaccine Immunol 2006;13:380–386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Goldblatt D, Vaz AR, Miller E. Antibody avidity as a surrogate marker of a successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis 1998;177:1112–1115. [DOI] [PubMed] [Google Scholar]
- 4. Vermont CL, van Dijken HH, van Limpt CJ, de Groot R, van Alphen L, van Den Dobbelsteen GP. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine. Infect Immun 2002;70:584–590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Gioia CAC, Sousa AB, Cruz SC, et al. Effect of booster dose of serogroup B meningococcal vaccine no antibody response to Neisseria meningitidis in mice vaccinated with different immunization schedules. FEMS Immunol Med Microbiol 2005;44:35–42. [DOI] [PubMed] [Google Scholar]
- 6. Gassman C, Bauer G. Avidity determination of IgG directed against tick‐borne encephalitis virus improves detection of current infections. J Med Virol 1997;51:242–251. [PubMed] [Google Scholar]
- 7. Jenun PA, Stray‐Pedersen B, Gundersen AG. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol 1997;35:1972–1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Alvarado‐Esquivel C, Sethi S, Janitschke K, Hahn H, Liesenfeld O. Comparison of two commercially available avidity tests for Toxoplasma‐specific OgG antibodies. Arch Med Res 2002;33:520–523. [DOI] [PubMed] [Google Scholar]
- 9. Korhonen MH, Brunstein J, Haario H, Katnikiv A, Rescaldani R, Hedman K. A new method with general diagnostic utility for the calculation of immunoglobulin avidity. Clin Diagn Lab Immunol 1999;6:725–728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Pollard AJ, Levin M. Vaccines for prevention of meningococcal disease. Pediatr Infect Dis J 2000;19:333–345. [DOI] [PubMed] [Google Scholar]
- 11. Milagres LG, Ramos SR, Sacchi CT. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect Immun 1994;62:4419–4424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Pollard AJ, Galassini R, van der Voort E. Humoral immune responses to Neisseria meningitidis in children. Infect Immun 1999;67:2441–2451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Pollard AJ, Levin M. Production of low‐avidity antibody by infants after infection with serogroup B meningococci. Lancet 2000;356:2065–2066. [DOI] [PubMed] [Google Scholar]
- 14. Singh M, Ugozzoli M, Kazzaz J, et al. A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine adjuvants. Vaccine 2005;24:1980–1986. [DOI] [PubMed] [Google Scholar]
- 15. Fukasawa LO, Dias WO, Schenkman PF, Raw I, Tanizaki MM. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice. FEMS Immunol Med Microbiol 2004;41:205–210. [DOI] [PubMed] [Google Scholar]
- 16. Kubrusly FS, Netto SL, Iortov D, Raw I, Araujo PS. A natural surfactant from pig lungs. Biotechnol Lett 2000;22:1251–1253. [Google Scholar]
- 17. Noronha CP, Struchiner CJ, Halloran ME. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case control study. Int J Epidemiol 1995;24:4419–4424. [DOI] [PubMed] [Google Scholar]
- 18. Boslego J, Garcia J, Cruz C. Efficacy, safety and immunogenicity of a meningococcal group B (15:P1.3) outer membrane vesicle vaccine in Iquiuqe, Chile. Vaccine 1995;13:821–829. [DOI] [PubMed] [Google Scholar]
- 19. Tapero JW, Lagos R, Ballesteros AM, et al. Immunogenicity of 2 serogroup B outer membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA 1999;281:1541–1543. [DOI] [PubMed] [Google Scholar]
- 20. Pollard AJ, Galassini R, Roupe EM, et al. Cellular immune responses to Neisseria meningitidis in children. Infect Immun 1999;67:2452–2463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Pollard AJ, Galassini R, Rouppe EM, et al. Humoral immune responses to Neisseria meningitidis in chidren. Infect Immun 1999;67:2441–2451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Korhonen MH, Brunstein J, Haario H, Katnikiv A, Rescaldani R, Hedmna K. A new method with general diagnostic utility for the calculation of immunoglobulin avidity. Clin Diagn Lab Immunol 1999;6:724–728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Pollard AJ, Levin M. Production of low‐avidity antibody after infection with serogroup B meningococci. Lancet 2000;356:265–2066. [DOI] [PubMed] [Google Scholar]
- 24. Vermont CL, van Dijken HH, de Groot R, van den Dobbelsteen GP. Porin A‐specific antibody avidity in patients who are convalescing from meningococcal disease. Pediatr Res 2005;58:149–152. [DOI] [PubMed] [Google Scholar]